跳至主要内容
临床试验/JPRN-UMIN000003999
JPRN-UMIN000003999已完成未知

A phase I clinical trial of cancer vaccine using multiple antigen epitope peptides for advanced cervical cancer - Cancer vaccine using multiple antigen peptides for advanced cervical cancer

Saitama medical university international medical center0 个研究点目标入组 18 人开始时间: 2010年8月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • severe heart disease patients treated with systemic corticosteroids

研究者

相似试验

已完成
1 期
A phase I clinical study of cancer vaccine with MAGE-A4/Survivin helper peptide for patients with advanced cancers expressing MAGE-A4 or Survivin antigeMAGE-A4- or Survivin-expressing refractory cancer patients (non origin-limited) or patients who refuse standard cancer therapy
JPRN-UMIN000003489Department of General Surgery, Hokkaido University Graduated School of Medicine12
已完成
1 期
The phase I,II clinical study of cancer vaccine for intractable malignant tumor expressing MAGE-A4-antigeIntractable malignant tumors expressing MAGE-A4 antigen
JPRN-UMIN000001999Department of Surgical Oncology, Hokkaido University Graduate School of Medicine18
已完成
1 期
Phase I clinical study of tumor-specific vaccine using novel tumor antigen SCRN1-derived HLA*0201 restricted epitope peptide against advanced gastric cancerAdvanced gastric cancer
JPRN-UMIN000001013Institute of Medical Science, University of Tokyo6
已完成
2 期
A phase II clinical study of cancer vaccine with Survivin helper peptide for patients with advanced/recurrent colorectal cancersSurvivin-expressing advanced/recurrent colorectal cancer patients or patients who refuse standard cancer therapy
JPRN-UMIN000007506Department of Gastroenterological Surgery I, Hokkaido University Graduated School of Medicine35
已完成
2 期
A phase II clinical study of cancer vaccine with Survivin helper peptide for patients with advanced/recurrent breast cancersA phase II clinical study of cancer vaccine with Survivin helper peptide for patients with advanced/recurrent breast cancers
JPRN-UMIN000007507Department of Breast and Endocrine Surgery, Hokkaido University Hospital40